Chemokine profile in women with moderate to severe anxiety and depression during pregnancy
Open accessThe DOI matches its Crossref record; 83 of the 84 references it cites were found in a registry or an index.
Abstract
Background: Cytokine levels have been extensively described in pregnant subjects under normal and pathological conditions, including mood-related disorders. Concerning chemokines, very few studies have reported their association with psychiatric disorders during pregnancy. Therefore, we explored the chemokine profile in women exhibiting anxiety and depression during late pregnancy in the present study. Methods: One hundred twenty-six pregnant women in the 3rd trimester of pregnancy, displaying moderate to severe anxiety (ANX) alone and women exhibiting moderate to severe anxiety with comorbid depression (ANX + DEP), and 40 control pregnant women without affective disorders (CTRL) were evaluated through the Hamilton Anxiety Rating Scale (HARS) and the Hamilton Depression Rating Scale (HDRS). Serum chemokine levels of MCP-1 (CCL2), RANTES (CCL5), IP-10 (CXCL10), Eotaxin (CCL11), TARC (CCL17), MIP-1α (CCL3), MIP-1β (CCL4), MIG (CXCL9), MIP-3α (CCL20), ENA-78 (CXCL5), GROα (CXCL1), I-TAC (CXCL11) and IL-8 (CXCL8)] were measured by immunoassay. Clinical, biochemical, and sociodemographic parameters were correlated with HARS and HDRS score values. Results: Serum levels of most chemokines were significantly higher in the ANX and in the ANX + DEP groups, when compared to the CTRL group. Positive correlations were observed between MIP-1α/CCL3, MIP-1β/CCL4, MCP-1/CCL2, MIP-3α/CCL20, RANTES/CCL5, Eotaxin/CCL11, and I-TAC/CXCL11 with high scores for anxiety (HARS) (p < 0.05) and for depression (HDRS) (p < 0.004). After controlling clinical measures for age + gwk + BMI, chemokines such as IL-8/CXCL8, MCP-1/CCL2 and MIP-1β/CCL4 were found associated with high scores for anxiety (p < 0.05) in the ANX group. TARC/CCL17 and Eotaxin/CCL11 showed significant associations with high scores for depression (p < 0.04) whereas, MCP-1/CCL2 and MIP-1α/CCL3 were significantly associated with high scores for anxiety (p < 0.05) in the ANX + DEP group. Using a multivariate linear model, high serum levels of MIP-1β/CCL4 and Eotaxin/CCL11 remained associated with depression (p < 0.01), while, IL-8/CXCL8, MIP-1β/CCL4, MCP-1/CCL2, and MIP-1α/CCL3 were associated with anxiety (p < 0.05) in the symptomatic groups. Conclusions: Our data show that serum levels of distinct chemokines are increased in women exhibiting high levels of affective symptoms during late pregnancy. Our results suggest that increased levels of anxiety, depressive symptoms, and mood-related disorders may promote changes in specific functional chemokines associated with a chronic inflammatory process. If not controlled, it may lead to adverse obstetric and negative neonate outcomes, child development and neuropsychiatric alterations in the postnatal life. Highlights: Chemokine levels increase in affective disorders during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, increased levels of MIP-1α and other chemokines correlated with anxiety and depression during the late stages of pregnancy [188].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [188]
In the citing paper
“A study on pregnant women in the third trimester correlated CCL5 and other chemokines with higher anxiety and anxiety/depression prevalence. However, after adjustment for clinical measures, the association with CCL5 did not prove significant [188].”
From Selected biomarkers of depression: what are the effects of cytokines and inflammation (2022) · cites this paper as [188]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Monocyte Chemoattractant Protein-1 (MCP-1): An Overview
Deshmane, S. L., Kremlev, S., Amini, S., & Sawaya, B. E. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0027 · Cited by 3,889
Prevalence of Depression During Pregnancy: Systematic Review
Bennett, H. A., Einarson, A., Taddio, A., Koren, G., & Einarson, T. R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000116689.75396.5f · Cited by 1,725 · cited 3×
“Different studies reported that the prevalence of perinatal depression ranges between 2 and 21% [5, 6], increasing to 31% upon the self-report scales used to screen the healthy pregnant population [6].”
BackgroundPrevalence of antenatal and postnatal anxiety: Systematic review and meta-analysis
Dennis, C.-L., Falah-Hassani, K., & Shiri, R. (2017) · British Journal of Psychiatry · doi:10.1192/bjp.bp.116.187179 · Cited by 1,491
The Chemokine Superfamily Revisited
Zlotnik, A., & Yoshie, O. (2012) · Immunity · doi:10.1016/j.immuni.2012.05.008 · Cited by 1,235
Gaynes, B. N., Gavin, N., Meltzer-Brody, S., Lohr, K. N., Swinson, T., Gartlehner, G., Brody, S., & Miller, W. C. (2005) · PsycEXTRA Dataset · doi:10.1037/e439372005-001 · Cited by 1,211
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
REVIEW ARTICLE: Th1/Th2/Th17 and Regulatory T‐Cell Paradigm in Pregnancy
Saito, S., Nakashima, A., Shima, T., & Ito, M. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00852.x · Cited by 1,109
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090 · cited 1×
“Both scales were shown to be reliable, specific, and sensitive clinician-rated instruments [43].”
Background
Cited by
Selected biomarkers of depression: what are the effects of cytokines and inflammation
Harsanyi, S., Kupcova, I., Danisovic, L., & Klein, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010578 · Cited by 299
The (neuro)inflammatory system in anxiety disorders and PTSD: Potential treatment targets
Sah, A., & Singewald, N. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108825 · Cited by 46
Tian, X., Wang, G., Teng, F., Xue, X., Pan, J., Mao, Q., Guo, D., Song, X., & Ma, K. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14519 · Cited by 43
Sominsky, L., O’Hely, M., Drummond, K. D., Cao, S., Collier, F., Dhar, P., Loughman, A., Dawson, S. L., Tang, M. L. K., Mansell, T., et al. (2023) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2023.07.005 · Cited by 42
Yang, H., Pan, Y., Chen, W., Yang, X., Liu, B., Yuan, N., & Zhang, X. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05059-2 · Cited by 38
Metadata
- Authors
- Camacho-Arroyo, I., Flores-Ramos, M., Mancilla-Herrera, I., Cruz, F. M. C., Hernández-Ruiz, J., Diaz, G. P., Labonne, B. F., del Pilar Meza-Rodríguez, M., & Gelman, P. L.
- Venue
- BMC Pregnancy and Childbirth
- Published
- 2021-12
- Volume
- 21
- Issue
- 1
- Pages
- 807-807
- ISSN
- 1471-2393 (ISSN-L)
- PMC
- PMC8642921
- OpenAlex
- W4200529942
- Cited by
- 41
- References
- 84
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 10 · 2023: 15 · 2022: 5
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor, 3 d)
- Locations
- BMC Pregnancy and Childbirth (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Funders
- Instituto Nacional de Perinatología (212250-3000-10916-01-16.)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- chemokines, pregnancy, anxiety, depression, mood disorders, maternal mental health, MCP-1, CCL3, carbon tetrachloride, RANTES, CCL17, eotaxin, CCL20, CCL8
- MeSH terms
- Adult, Anxiety, Cross-Sectional Studies, Depression, Female, Humans, Mexico, Pregnancy, Pregnancy Complications, Pregnancy Trimester, Third, Psychiatric Status Rating Scales, Chemokines, Mood Disorders, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Chemokine profile in women with moderate to severe anxiety and depression during pregnancy. https://app.cochat.ai/papers/10.1186/s12884-021-04225-2
- The paper
- Camacho-Arroyo, I., Flores-Ramos, M., Mancilla-Herrera, I., Cruz, F. M. C., Hernández-Ruiz, J., Diaz, G. P., Labonne, B. F., del Pilar Meza-Rodríguez, M., & Gelman, P. L. (2021). Chemokine profile in women with moderate to severe anxiety and depression during pregnancy. BMC Pregnancy and Childbirth. https://doi.org/10.1186/s12884-021-04225-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.